Market Place
Sourcing Support
Novus Announces Name Change to Eledon Pharmaceuticals; Provides
04 Jan 2021 //
GLOBENEWSWIRE
Novus Announces First Patient Enrolled in Ph 2a Clinical Trial of Anti-CD40L
02 Nov 2020 //
BIOSPACE
Novus Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L
02 Nov 2020 //
BUSINESSWIRE
Novus Therapeutics announces 1-for-18 reverse stock split
02 Oct 2020 //
SEEKINGALFA
Novus Therapeutics Announces One-for-Eighteen Reverse Stock Split
02 Oct 2020 //
BUSINESSWIRE
Novus Finalizes Acquisition of Anelixis to Further Develop AT-1501
16 Sep 2020 //
BIOSPACE
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
15 Sep 2020 //
BIOSPACE
Novus Therapeutics plunge deep into penny stock territory after failed ear trial
03 Jun 2020 //
ENDPTS
Novus Therapeutics Announces Topline Results of Phase 2a Clinical Trial OP0201
01 Jun 2020 //
BUSINESSWIRE
Novus Therapeutics Announces Topline Results of Ph2a Clinical Trial of OP0201
01 Jun 2020 //
BUSINESSWIRE
Novus Therapeutics Completes Enrollment of Phase 2a Trial of OP0201
02 Mar 2020 //
BUSINESSWIRE
Novus Therapeutics Receives FDA Guidance on OP0201 Phase 2a Study
29 Oct 2019 //
BUSINESSWIRE
Novus Therapeutics Announces Results of 2 SingleDose OP0201 Ph1 Clinical Trials
22 Apr 2019 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.